SLC1A5 and colonic neoplasm: In conclusion, the present study demonstrated that Lobetyolin exhibited anti‐cancer effect on colon cancer HCT‐116 cells through the apoptosis regulated by ASCT2‐modulated glutamine metabolism, which was governed by p53.